… the inhaled corticosteroid (ICS) or oral corticosteroid (OCS) … assessment of corticosteroid
use in this group of patients with or … of patients with regards to the use of corticosteroids amid …

… an association between systemic corticosteroid use and the development of peptic ulcer
disease. Whether patients with COPD and an associated history of tobacco use history are at …

… use of ICS on clinical outcomes for patients with COPD hospitalized with pneumonia. …
corticosteroids use and clinical outcomes for patients with chronic obstructive pulmonary disease …

… the administration of systemic corticosteroids to patients with COPD exacerbations. Owing
to the historical lack of unifying diagnostic criteria for both COPD and acute exacerbation, the …

… patients with COPD. This article is based on a review of the literature (PubMed: COPD AND
inhaled corticosteroids… evidence for the efficacy and safety of ICS use in patients with COPD. …

… patients with COPD benefit from corticosteroids, whereas others do not, maybe not even
while receiving higher doses. Factors determining treatment response in patients with COPD …

… ICU patients allows estimation of the level of evidence overall and in patients admitted to …
We included RCTs evaluating the efficacy and safety of systemic corticosteroids in COPD …

… Our meta-analysis suggests that COPD patients treated with inhaled corticosteroids experience
significantly fewer exacerbations than patients on placebo. The relative risk reduction is …

… Patients with a new diagnosis of COPD (and without a previous asthma diagnosis) are likely
to have a low level of previous corticosteroid use that … The cumulative corticosteroid dose is …

… comparing COPD exacerbation rates between patients receiving … of inhaled corticosteroid
use among patients with COPD … large cohort of patients with COPD, whether the use of ICS is …